Electromed (ELMD) Competitors $20.27 +1.25 (+6.57%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$20.45 +0.18 (+0.91%) As of 08/22/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELMD vs. BBNX, AXGN, BVS, SMLR, ZIMV, AVNS, KIDS, CBLL, TMCI, and DCTHShould you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Beta Bionics (BBNX), AxoGen (AXGN), Bioventus (BVS), Semler Scientific (SMLR), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), OrthoPediatrics (KIDS), CeriBell (CBLL), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Electromed vs. Its Competitors Beta Bionics AxoGen Bioventus Semler Scientific ZimVie AVANOS MEDICAL OrthoPediatrics CeriBell Treace Medical Concepts Delcath Systems Beta Bionics (NASDAQ:BBNX) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Does the media refer more to BBNX or ELMD? In the previous week, Beta Bionics had 7 more articles in the media than Electromed. MarketBeat recorded 9 mentions for Beta Bionics and 2 mentions for Electromed. Electromed's average media sentiment score of 1.20 beat Beta Bionics' score of 0.44 indicating that Electromed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Electromed 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is BBNX or ELMD more profitable? Electromed has a net margin of 11.34% compared to Beta Bionics' net margin of 0.00%. Electromed's return on equity of 15.71% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Electromed 11.34%15.71%13.37% Do analysts recommend BBNX or ELMD? Beta Bionics presently has a consensus target price of $22.56, suggesting a potential upside of 32.29%. Electromed has a consensus target price of $33.50, suggesting a potential upside of 65.27%. Given Electromed's stronger consensus rating and higher probable upside, analysts plainly believe Electromed is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00 Do institutionals & insiders hold more shares of BBNX or ELMD? 40.8% of Electromed shares are owned by institutional investors. 14.0% of Electromed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable valuation & earnings, BBNX or ELMD? Electromed has lower revenue, but higher earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$78.02M9.50-$54.76MN/AN/AElectromed$61.44M2.77$5.15M$0.7925.66 SummaryElectromed beats Beta Bionics on 10 of the 14 factors compared between the two stocks. Get Electromed News Delivered to You Automatically Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELMD vs. The Competition Export to ExcelMetricElectromedElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$169.98M$39.56M$5.76B$20.92BDividend YieldN/AN/A4.41%3.58%P/E Ratio27.033.4131.1029.13Price / Sales2.77250.60435.2652.98Price / Cash41.3641.3637.7323.54Price / Book3.972.259.535.45Net Income$5.15M-$2.66M$3.26B$992.10M7 Day Performance7.08%3.58%2.10%2.61%1 Month Performance6.35%10.42%2.82%1.46%1 Year Performance27.48%141.59%30.56%10.72% Electromed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELMDElectromed1.9547 of 5 stars$20.27+6.6%$33.50+65.3%+31.4%$169.98M$61.44M27.03160Positive NewsBBNXBeta Bionics2.6296 of 5 stars$14.30-3.0%$22.56+57.7%N/A$640.75M$65.12M0.00294News CoveragePositive NewsInsider TradeAXGNAxoGen2.765 of 5 stars$14.01+0.8%$26.00+85.6%+31.7%$639.58M$187.34M-140.09450Short Interest ↑BVSBioventusN/A$6.93+0.1%$13.75+98.4%-22.7%$569.26M$564.14M-11.361,200SMLRSemler Scientific3.4863 of 5 stars$35.28-2.4%$81.75+131.7%+11.0%$534.89M$56.29M4.30120Gap UpZIMVZimVie0.7047 of 5 stars$18.83+0.1%$17.75-5.7%+11.2%$530.46M$449.75M-26.901,770Positive NewsShort Interest ↑AVNSAVANOS MEDICAL3.2892 of 5 stars$10.52-2.8%N/A-49.6%$502.08M$687.80M8.872,227Short Interest ↑KIDSOrthoPediatrics3.9369 of 5 stars$18.81-0.5%$34.14+81.5%-32.9%$474.14M$204.73M0.00200CBLLCeriBell2.3431 of 5 stars$12.12-6.1%$32.14+165.2%N/A$473.33M$65.44M-4.05N/APositive NewsTMCITreace Medical Concepts2.6157 of 5 stars$6.39+4.2%$9.83+53.9%+24.2%$387.25M$209.36M0.00250DCTHDelcath Systems2.6322 of 5 stars$10.51+5.0%$24.50+133.1%+41.3%$350.16M$37.21M83.4260Short Interest ↑ Related Companies and Tools Related Companies BBNX Competitors AXGN Competitors BVS Competitors SMLR Competitors ZIMV Competitors AVNS Competitors KIDS Competitors CBLL Competitors TMCI Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELMD) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access